You are viewing the site in preview mode

Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma

Fig. 1

MTCH2 expression is increased in glioma tissues and indicates poor prognosis. a A Pan-cancer diagram showing the increased MTCH2 expression in brain gliomas. bReal-time PCR results showing increased mRNA level of MTCH2 in glioma tissues compared to paired adjacent brain tissues (n = 32). c, d Western blots (c) and quantifications (d) showing increased proteins of MTCH2 in glioma tissues compared to paired adjacent brain tissues (n = 23). e, f Survival analysis using clinical information from TCGA (e) and CGGA (f) dataset. Patients are divided into low and high MTCH2 groups by median expression level

Back to article page

Molecular Medicine

ISSN: 1528-3658